Skip to main content

Table 3 Clinical outcomes

From: The efficacy and safety of peripheral intravenous parenteral nutrition vs 10% glucose in preterm infants born 30 to 33 weeks’ gestation: a randomised controlled trial

Outcome P-PN (n = 42) Control (n = 50) Adjusted effecta (95% CI) Adjusted P valuea
Days of feeding intolerance, mean, SD, db 0.6 (1.2) 0.6 (1.0) 1.0 (0.5, 2.1)c 1.0
Days to full enteral feeds (120 mLs/kg/d), mean, SD, d 6.6 (2.4) 6.2 (1.7) 1.1 (0.9, 1.2)c 0.3
Hypoglycemia requiring treatment 4.0 (9.5) 8.0 (16.0) 0.5 (0.1, 2.0)d 0.4
IPPV via endotracheal tube 3.0 (7.1) 4.0 (8.0) 1.1 (0.2, 5.9)d 0.9
Nasal CPAP 26.0 (61.9) 37.0 (74.0) 0.6 (0.2, 1.5)d 0.3
Days of any respiratory support, mean, SD, d 4.2 (7.0) 5.3 (12.0) 0.8 (0.4, 1.5)c 0.5
Confirmed sepsise 2 (4.8) 1 (2.0) 2.1 (0.2, 19.0)d 0.5
Breastmilk (any) on discharge home (n = 38/46) 33 (87) 41 (89) 0.8 (0.2, 3.3)d 0.8
Length of hospital stay, mean, SD, d 35.5 (10.5) 35.6 (13.8) 1.0 (0.9, 1.1)c 0.8
  1. Data are presented as n (%) unless otherwise indicated
  2. a Adjusted for sex and gestational age 30+ 0 to 31+ 6 and 32+ 0 to 33+ 6 weeks
  3. b Number of days on which one or more feeds were stopped
  4. c Adjusted ratio of means
  5. d Adjusted odds ratio
  6. e P-PN group rhinovirus n = 1, central line sepsis n = 1; Control group rhinovirus n = 1